Deutsche Bank Ag\ Immunity Bio, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 333,519 shares of IBRX stock, worth $883,825. This represents 0.0% of its overall portfolio holdings.

Number of Shares

333,519

Previous 179,141 86.18%

Holding current value

$883,825

Previous $1.13 Million 9.28%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$3.32 - $6.7 $512,534 - $1.03 Million	154,378 Added 86.18%	333,519 $1.24 Million
Q2 2024 Aug 14, 2024	BUY	$4.82 - $9.15 $572,775 - $1.09 Million	118,833 Added 197.04%	179,141 $1.13 Million
Q1 2024 May 15, 2024	SELL	$3.23 - $6.17 $288,816 - $551,702	-89,417 Reduced 59.72%	60,308 $323,000
Q4 2023 Feb 14, 2024	BUY	$1.25 - $5.21 $119,985 - $500,097	95,988 Added 178.63%	149,725 $751,000
Q2 2023 Aug 14, 2023	SELL	$1.53 - $6.41 $3,843 - $16,101	-2,512 Reduced 4.47%	53,737 $149,000
Q1 2023 May 15, 2023	BUY	$1.35 - $4.78 $20,079 - $71,097	14,874 Added 35.95%	56,249 $102,000
Q4 2022 Feb 13, 2023	SELL	$4.35 - $6.77 $62,209 - $96,817	-14,301 Reduced 25.69%	41,375 $209,000
Q3 2022 Nov 14, 2022	BUY	$3.65 - $6.43 $50,366 - $88,727	13,799 Added 32.95%	55,676 $277,000
Q2 2022 Aug 11, 2022	BUY	$2.68 - $6.14 $8,943 - $20,489	3,337 Added 8.66%	41,877 $156,000
Q1 2022 May 13, 2022	SELL	$5.05 - $7.53 $21,563 - $32,153	-4,270 Reduced 9.97%	38,540 $216,000
Q4 2021 Feb 11, 2022	SELL	$5.67 - $10.18 $6,435 - $11,554	-1,135 Reduced 2.58%	42,810 $260,000
Q3 2021 Nov 04, 2021	SELL	$9.17 - $14.24 $3,915 - $6,080	-427 Reduced 0.96%	43,945 $428,000
Q2 2021 Aug 11, 2021	BUY	$13.41 - $22.4 $287,161 - $479,673	21,414 Added 93.27%	44,372 $634,000
Q1 2021 May 13, 2021	BUY	$12.83 - $42.25 $294,551 - $969,975	22,958 New	22,958 $545,000

Others Institutions Holding IBRX

# of Institutions

205

Shares Held

70M

Call Options Held

1.68M

Put Options Held

1.31M

View Full List

About ImmunityBio, Inc.

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.06B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

More about IBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account